04
FDA opens a comment window on autonomous clinical AI, closing October 19
verifiedHealthcareRegulation
Thursday, October 8, 2026
Confidence
Medium · — regulator primary; comment specifics will determine the eventual rule
Evidence
FDA docket + KFF summary
The FDA is accepting public comment on evaluating autonomous AI in direct clinical roles — a category the agency has not previously ruled on. The window closes October 19.
- Covers AI acting in clinical workflows without a clinician-in-the-loop step.
- Framework will shape 510(k) and De Novo pathways. Source: KFF.
Sources